loading
Schlusskurs vom Vortag:
$40.51
Offen:
$40.3
24-Stunden-Volumen:
190.22K
Relative Volume:
0.29
Marktkapitalisierung:
$1.73B
Einnahmen:
$17.39M
Nettoeinkommen (Verlust:
$-135.89M
KGV:
-8.7543
EPS:
-4.64
Netto-Cashflow:
$-123.00M
1W Leistung:
-1.84%
1M Leistung:
-5.38%
6M Leistung:
-26.60%
1J Leistung:
+43.91%
1-Tages-Spanne:
Value
$39.19
$40.80
1-Wochen-Bereich:
Value
$39.19
$42.00
52-Wochen-Spanne:
Value
$20.08
$57.28

Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile

Name
Firmenname
Tarsus Pharmaceuticals Inc
Name
Telefon
(949) 409-9820
Name
Adresse
15440 LAGUNA CANYON ROAD, IRVINE
Name
Mitarbeiter
323
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
TARS's Discussions on Twitter

Vergleichen Sie TARS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TARS
Tarsus Pharmaceuticals Inc
40.62 1.73B 17.39M -135.89M -123.00M -4.64
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
454.86 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.28 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.40 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
553.88 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.85 28.51B 3.81B -644.79M -669.77M -6.24

Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-02 Fortgesetzt Oppenheimer Outperform
2025-05-27 Fortgesetzt H.C. Wainwright Buy
2023-11-20 Eingeleitet Goldman Neutral
2023-07-18 Eingeleitet William Blair Outperform
2023-05-18 Eingeleitet Guggenheim Buy
2022-08-01 Eingeleitet Barclays Overweight
2021-12-21 Eingeleitet H.C. Wainwright Buy
2021-11-23 Eingeleitet Oppenheimer Outperform
2020-11-10 Eingeleitet BofA Securities Buy
2020-11-10 Eingeleitet Jefferies Buy
2020-11-10 Eingeleitet Ladenburg Thalmann Buy
2020-11-10 Eingeleitet Raymond James Strong Buy
Alle ansehen

Tarsus Pharmaceuticals Inc Aktie (TARS) Neueste Nachrichten

pulisher
Jun 18, 2025

Tarsus Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks

Jun 18, 2025
pulisher
Jun 17, 2025

Tarsus Pharmaceuticals Becomes Oversold (TARS) - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

When (TARS) Moves Investors should Listen - news.stocktradersdaily.com

Jun 17, 2025
pulisher
Jun 17, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of “Buy” by Brokerages - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

Rhumbline Advisers Increases Stock Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Jun 16, 2025
pulisher
Jun 12, 2025

Tarsus Pharmaceuticals’ SWOT analysis: XDEMVY’s success propels stock growth - Investing.com Australia

Jun 12, 2025
pulisher
Jun 12, 2025

Tarsus Pharmaceuticals’ SWOT analysis: XDEMVY’s success propels stock growth By Investing.com - Investing.com India

Jun 12, 2025
pulisher
Jun 12, 2025

Insider Sell: Aziz Mottiwala Sells 17,500 Shares of Tarsus Pharm - GuruFocus

Jun 12, 2025
pulisher
Jun 11, 2025

Tarsus Pharmaceuticals CCO sells $765,800 in stock - Investing.com Australia

Jun 11, 2025
pulisher
Jun 11, 2025

Tarsus Pharmaceuticals CCO sells $765,800 in stock By Investing.com - Investing.com Canada

Jun 11, 2025
pulisher
Jun 10, 2025

Certain Common stock of Tarsus Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 11-JUN-2025. - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

Certain Stock Options of Tarsus Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 11-JUN-2025. - MarketScreener

Jun 10, 2025
pulisher
Jun 09, 2025

Tarsus Pharmaceuticals at Goldman Sachs Conference: Strategic Growth Focus By Investing.com - Investing.com Canada

Jun 09, 2025
pulisher
Jun 09, 2025

Transcript : Tarsus Pharmaceuticals, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 01 - MarketScreener

Jun 09, 2025
pulisher
Jun 08, 2025

Stocks Showing Improving Market Leadership: Tarsus Pharmaceuticals Earns 87 RS Rating - MSN

Jun 08, 2025
pulisher
Jun 07, 2025

Squarepoint Ops LLC Sells 51,329 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Jun 07, 2025
pulisher
Jun 04, 2025

Where are the Opportunities in (TARS) - news.stocktradersdaily.com

Jun 04, 2025
pulisher
Jun 03, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Now Covered by Oppenheimer - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Oppenheimer Adjusts Price Target on Tarsus Pharmaceuticals to $75 From $72, Maintains Outperform Rating - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

TARS: Oppenheimer Ups Tarsus Pharmaceuticals Price Target to $75 | TARS Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

TARS: Oppenheimer Ups Tarsus Pharmaceuticals Price Target to $75 - GuruFocus

Jun 02, 2025
pulisher
May 30, 2025

What is HC Wainwright’s Estimate for TARS Q2 Earnings? - Defense World

May 30, 2025
pulisher
May 30, 2025

Nuveen Asset Management LLC Sells 15,186 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

May 30, 2025
pulisher
May 29, 2025

Tarsus to Participate in Upcoming Investor Conferences | TARS Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Tarsus Lines Up Triple Conference Appearances: William Blair, Jefferies, and Goldman Sachs in June - Stock Titan

May 29, 2025
pulisher
May 29, 2025

Tarsus to Participate in Upcoming Investor Conferences - GlobeNewswire

May 29, 2025
pulisher
May 29, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Purchased by Ameriprise Financial Inc. - Defense World

May 29, 2025
pulisher
May 28, 2025

BNP Paribas Financial Markets Buys New Shares in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

May 28, 2025
pulisher
May 28, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Stock Rating Upgraded by HC Wainwright - Defense World

May 28, 2025
pulisher
May 28, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Now Covered by HC Wainwright - Defense World

May 28, 2025
pulisher
May 28, 2025

TARS: HC Wainwright & Co. Initiates Buy Rating with $72 Target | - GuruFocus

May 28, 2025
pulisher
May 27, 2025

Tarsus Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga

May 27, 2025
pulisher
May 27, 2025

TARS: HC Wainwright & Co. Initiates Buy Rating with $72 Target | TARS Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

TARS: H.C. Wainwright Initiates Coverage with a Buy Rating | TARS Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Tarsus Pharmaceuticals Advances Novel Treatments for Eye and Vector-Borne Diseases - utahdailynewswire.com

May 27, 2025
pulisher
May 26, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $1.16 Million Stock Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

May 26, 2025
pulisher
May 23, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Average Recommendation of “Buy” from Brokerages - Defense World

May 23, 2025
pulisher
May 21, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Purchased by Bank of America Corp DE - Defense World

May 21, 2025
pulisher
May 20, 2025

Tarsus Pharmaceuticals at H.C. Wainwright: Expanding Horizons with Xdemvy By Investing.com - Investing.com Canada

May 20, 2025
pulisher
May 19, 2025

Tarsus Pharmaceuticals Shows Rising Price Performance With Jump To 84 RS Rating - inkl

May 19, 2025
pulisher
May 14, 2025

When the Price of (TARS) Talks, People Listen - news.stocktradersdaily.com

May 14, 2025
pulisher
May 14, 2025

Tarsus Pharmaceuticals (TARS) Loses -15.59% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

May 14, 2025
pulisher
May 14, 2025

Tarsus Pharmaceuticals Inc Enters Oversold Territory (TARS) - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Acquired by Northern Trust Corp - Defense World

May 14, 2025
pulisher
May 14, 2025

Transcript : Tarsus Pharmaceuticals, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 03 - marketscreener.com

May 14, 2025
pulisher
May 13, 2025

Tarsus Pharmaceuticals Breaks Below 200-Day Moving AverageNotable for TARS - Nasdaq

May 13, 2025
pulisher
May 13, 2025

Tarsus Pharmaceuticals (TARS) Expected to Announce Earnings on Wednesday - Defense World

May 13, 2025
pulisher
May 12, 2025

Tarsus Pharmaceuticals: The "Get Big Fast" Approach Could Pay Off (NASDAQ:TARS) - Seeking Alpha

May 12, 2025
pulisher
May 08, 2025

Tarsus to Participate in Upcoming Investor Conferences | TARS St - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Dimensional Fund Advisors LP Sells 62,658 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

May 08, 2025
pulisher
May 07, 2025

Tarsus Pharmaceuticals Reports First Quarter 2025 Sales Growth - VisionMonday.com

May 07, 2025

Finanzdaten der Tarsus Pharmaceuticals Inc-Aktie (TARS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.05
price up icon 1.77%
$35.85
price down icon 0.53%
$21.32
price down icon 0.15%
$99.46
price down icon 1.19%
$108.80
price up icon 2.21%
biotechnology ONC
$246.51
price up icon 1.76%
Kapitalisierung:     |  Volumen (24h):